Toxoplasmosis (acute & in pregnancy)
Toxo · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Toxoplasma gondii causes mild/self-limited illness in the immunocompetent but serious disease in pregnancy (congenital infection), immunosuppression (encephalitis) and the eye (chorioretinitis). Management targets prevention of fetal transmission and tissue damage.
Red flags
- Maternal seroconversion in pregnancy
- Sight-threatening macular/optic nerve chorioretinitis
- Focal neurological deficit in immunosuppressed
- Severe disseminated disease
- Neonatal signs of congenital infection
Assessment
Differential diagnosis
- Infectious mononucleosis / other causes of lymphadenopathy
- Lymphoma
- Cerebral lymphoma (in HIV cerebral toxoplasmosis)
- Other congenital infections (CMV, rubella)
- Other causes of chorioretinitis
Investigations
- Toxoplasma IgG and IgM (with avidity testing in pregnancy)
- PCR of amniotic fluid for suspected congenital infection
- MRI brain (ring-enhancing lesions) in immunosuppressed
- Ophthalmological assessment for ocular disease
- HIV test / immune status
- Fetal ultrasound surveillance in maternal infection
Management
- Confirm acute versus past infection with serology and IgG avidity
- In immunocompetent adults with lymphadenopathy, usually reassure (self-limiting)
- In pregnancy, assess timing of maternal infection and transmission risk
- Start spiramycin to reduce vertical transmission while awaiting fetal testing
- Perform amniocentesis PCR to confirm fetal infection
- Switch to pyrimethamine-sulfadiazine-folinic acid if fetal infection confirmed (after first trimester)
- Treat ocular disease threatening vision with anti-toxoplasma therapy +/- steroids
- For cerebral toxoplasmosis in HIV, treat and optimise ART (covered separately)
- Arrange paediatric/neonatal follow-up for exposed infants
- Counsel on prevention (food hygiene, cat litter precautions)
- Monitor for drug toxicity (marrow suppression - give folinic acid)
- Long-term ophthalmology follow-up for ocular disease
Drugs & doses
Spiramycin 1 g PO three times daily (to prevent vertical transmission, maternal infection)
Pyrimethamine 50 mg PO daily + sulfadiazine 1 g PO four times daily + folinic acid 10-20 mg daily (confirmed fetal/active disease)
Pyrimethamine + sulfadiazine + folinic acid for ocular toxoplasmosis (plus corticosteroid if sight-threatening)
Co-trimoxazole as an alternative regimen in some settings
Disposition
Outpatient obstetric/ID or ophthalmology; fetal medicine referral in pregnancy; neonatal follow-up.
Complications & pitfalls
- Congenital toxoplasmosis (chorioretinitis, intracranial calcification, hydrocephalus)
- Vision loss from chorioretinitis
- Cerebral toxoplasmosis in immunosuppression
- Drug-induced marrow suppression
- Reactivation with immunosuppression
Exam pearls
- Spiramycin reduces transmission but does not treat established fetal infection
- IgG avidity helps date infection relative to conception
- Always co-prescribe folinic acid with pyrimethamine to protect the marrow
- Most immunocompetent infections need no treatment
- Prevention counselling (undercooked meat, cat litter) is key in pregnancy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.